Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer.
Salatino M, Croci DO, Bianco GA, Ilarregui JM, Toscano MA, Rabinovich GA. Salatino M, et al. Expert Opin Biol Ther. 2008 Jan;8(1):45-57. doi: 10.1517/14712598.8.1.45. Expert Opin Biol Ther. 2008. PMID: 18081536 Review.
This endogenous lectin widely expressed at sites of inflammation and tumour growth, has been postulated as an attractive immunosuppressive agent to restore immune cell tolerance and homeostasis in autoimmune and inflammatory settings. On the other hand, galectin- …
This endogenous lectin widely expressed at sites of inflammation and tumour growth, has been postulated as an attractive immunosuppressive a …
Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation.
Sundblad V, Morosi LG, Geffner JR, Rabinovich GA. Sundblad V, et al. J Immunol. 2017 Dec 1;199(11):3721-3730. doi: 10.4049/jimmunol.1701172. J Immunol. 2017. PMID: 29158348 Free article. Review.
Regulatory signals provide negative input to immunological networks promoting resolution of acute and chronic inflammation. Galectin-1 (Gal-1), a member of a family of evolutionarily conserved glycan-binding proteins, displays broad anti-inflammatory and pror …
Regulatory signals provide negative input to immunological networks promoting resolution of acute and chronic inflammation. Galectin- …